ArticlePain reports2025
Validation of the menstrual sensitivity index in adolescents.
Article in Pain reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Introduction: The Menstrual Sensitivity Index (MSI), assessing the attunement to and fear of menstrual symptoms, was recently developed and validated in an adult sample. Objectives: The objective of this study was to validate the MSI in adolescents. Methods: One hundred forty-one girls aged 13 to 19 participated in a larger parent study on primary dysmenorrhea, and their data were used in the present study. Girls participated at 2 timepoints: baseline (N = 141) and a 1-year follow-up (N = 115). At each timepoint, participants completed the MSI and a variety of self-report measures. Results: A confirmatory factor analysis supports the previously identified factors of the MSI (somatic anxiety, fear/danger, and medication) in adolescent girls. The MSI demonstrates good item-total correlations, internal consistency, and test-retest reliability. The MSI converged most strongly with pain catastrophizing and diverged most strongly from body pain. Conclusion: The MSI is a valid and reliable measure of attunement to and fear of menstrual symptoms in adolescents. Unlike research in adult women demonstrating convergence between the MSI and menstrual pain and menstrual symptom severity, the divergence between the MSI and these variables in the current study suggests that, for adolescents, menstrual sensitivity is more strongly related to fear of pain than menstrual pain itself. These findings provide considerations for future research and clinical practice addressing menstrual pain and symptoms in adolescents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.